Prenosis

About:

An AI company enabling precision medicine for infection. The world leader in data and insights for abnormal immune response in acute care.

Website: http://www.prenosis.com

Twitter/X: prenosisinc

Top Investors: National Science Foundation, PACE Healthcare Capital, National Institute of General Medical Science, Defense Threat Reduction Agency (DTRA)

Description:

Prenosis, Inc. is an artificial intelligence company enabling precision medicine in acute care. At Prenosis we believe healthcare should be tailored to individual biology. With our data-driven approach to fast-moving biology in acute care environments, we're ushering in a new era of precision medicine in acute care. Our Immunix™ precision medicine platform generates proprietary biological insights to rapidly develop precision medicine products and enables the real-time delivery of optimal precision therapy in acute care. The platform is based on the world's largest and fastest-growing biomarker-clinical dataset for rapid immune response. Using Immunix™, we created and validated the Sepsis ImmunoScore™, the first FDA-authorized AI diagnostic for sepsis. At Prenosis, we enable the healthcare ecosystem to see people differently. More information at: www.prenosis.com

Total Funding Amount:

$11.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Chicago, Illinois, United States

Founded Date:

2014-01-01

Contact Email:

bobby.reddy.jr(AT)prenosis.com

Founders:

Bobby Reddy, Jr., Rashid Bashir

Number of Employees:

11-50

Last Funding Date:

2023-07-12

IPO Status:

Private

© 2024 MyAiNote.com